0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Reports |

Comparison of Commercially Available Parathyroid Hormone Immunoassays in the Differential Diagnosis of Hypercalcemia Due to Primary Hyperparathyroidism or Malignancy

LAWRENCE G. RAISZ, M.D.; CHAITANYA H. YAJNIK, M.D.; RICHARD S. BOCKMAN, M.D.; and BRUCE F. BOWER, M.D.
[+] Article and Author Information

University of Connecticut Health Center, Farmington, ConnecticutMemorial Sloan-Kettering Cancer Center, New York, New York

University of Connecticut Health Center, Farmington, ConnecticutMemorial Sloan-Kettering Cancer Center, New York, New York


Ann Intern Med. 1979;91(5):739-740. doi:10.7326/0003-4819-91-5-739
Text Size: A A A
This excerpt has been provided in the absence of an abstract.

The measurement of immunoreactive parathyroid hormone (iPTH) has become an important part of the differential diagnosis of hypercalcemia. High values in the absence of renal failure are considered diagnostic of primary hyperparathyroidism. It has been suggested that the finding of normal iPTH in the presence of elevated serum calcium concentration also should be considered diagnostic of primary hyperparathyroidism, on the assumption that iPTH should be suppressed if hypercalcemia were due to another cause (1, 2). However, normal or even somewhat elevated iPTH values have been reported in patients with hypercalcemia due to malignancy (3, 4). These values have been ascribed

...

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)